Skip to main content
Media Alert Press Media Alert Press Check a URL
Saturday, October 10, 2026
Live
UAW leader reviled by Trump declares victory in reelectionHead of ICE enforcement says man shot in NYC with child in backseat “weaponized his vehicle”The history of public executions in the U.S. amid Nidal Hasan’s planned firing squad deathCategory 3 Hurricane Isaias just hours away from making landfall on Gulf CoastRepublicans divided over Pentagon’s plan to livestream execution of Fort Hood shooterWhat to watch as legal drama “Cupertino” premieres on CBS
28,487 Ledger Records 56 added in the last hour1,599 in the last 24 hours
What is counted?

Counted at 00:27:32 UTC. These figures count ledger entries that have a record hash, the same entries as the total. The newest of them was added at 00:27:30 UTC on 2026-10-10. Entries are added in batches when MAP checks its feeds, so the figures vary through the day.

World

Women with PMOS should get subsidised weight loss drugs, advocates say

By Tess Ikonomou The Guardian
Women with PMOS should get subsidised weight loss drugs, advocates say

Feed excerpt — reported by The Guardian

With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-labelGet our breaking news email, free app or daily news podcastWomen living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition. Continue reading…

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at The Guardian →

Original Source

This article was syndicated from The Guardian. All rights remain with the original publisher.

Powered by